Lv41
620 积分 2021-08-14 加入
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
6小时前
待确认
The dormant cancer cell life cycle
2个月前
已完结
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
7个月前
已完结
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies
7个月前
已完结
How can we integrate the biology of breast cancer cell dormancy into clinical practice?
7个月前
已完结
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer
9个月前
已完结
Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer – Current Evidence and Future Directions
1年前
已完结
Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread
1年前
已完结
Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes
1年前
已完结
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
1年前
已完结
皖公网安备34019202002308
